| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Orderbuch | Analysen | |||||
| Historisch | ||||||
|
06.06.2025 16:45:04
|
EQS-News: Viromed Medical AG plans change in the Supervisory Board and Chairman of the Supervisory Board
|
EQS-News: Viromed Medical AG
/ Key word(s): Personnel
Viromed Medical AG plans change in the Supervisory Board and Chairman of the Supervisory Board Pinneberg, June 06, 2025 - Viromed Medical AG ("Viromed", ticker: VMED; ISIN: DE000A3MQR65), a medical technology company and pioneer in cold plasma technology, proposes to the Annual General Meeting on July 29, 2025 that Dr. Thomas Gutschlag be elected as a new member of the company's Supervisory Board. Dr. Gutschlag will then also take over as Chairman of the Supervisory Board. The current Chairman of the Supervisory Board, Dr. Jan Delphendahl, will resign from office at the end of the Annual General Meeting. Uwe Perbandt, founder and CEO of Viromed, thanked Dr. Delphendahl for his outstanding work and commitment over the past years. Under his leadership, the company was able to achieve significant milestones and successfully implement strategically important decisions. Dr. Thomas Gutschlag is the founder and Chairman of the Supervisory Board of Deutsche Rohstoff AG. With his many years of experience in the financial market, he will further strengthen the entrepreneurial expertise of the Supervisory Board and support the company on its growth path. The current Supervisory Board members Frank Otto and Dr. Markus Perbandt will remain on the Supervisory Board. Dr. Gutschlag purchased 100,000 shares from Uwe Perbandt's holdings in April. It is planned that he will acquire further shares. "We are very pleased to welcome Dr. Thomas Gutschlag, an experienced and competent personality, to the top of our Supervisory Board. His know-how will help us to successfully master our strong growth," says Uwe Perbandt, CEO of Viromed Medical AG. About Viromed Medical AG Viromed Medical AG specializes in the development, manufacture and distribution of medical products. The operating business of the company, which has been listed on the Frankfurt stock exchange since October 2022, focuses on the distribution of innovative cold atmospheric plasma (CAP) technology for medical applications via its wholly owned subsidiary, Viromed Medical GmbH. Viromed can draw on a broad customer base in the DACH region and beyond. Viromed Medical AG is pursuing the goal of further advancing the use of CAP in medicine in the coming years and realizing the corresponding growth potential.
The translation is provided for information purposes only. In the event of any discrepancy between the German and English versions of this press release, the German version shall prevail. Contact Viromed Medical AG Uwe Perbandt Media inquiries MC Services AG Anne Hennecke / Dr. Kai Schmitz
06.06.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. |
| Language: | English |
| Company: | Viromed Medical AG |
| Flensburger Straße 18 | |
| 25421 Pinneberg | |
| Germany | |
| E-mail: | kontakt@viromed-medical.de |
| Internet: | https://www.viromed-medical-ag.de/ |
| ISIN: | DE000A3MQR65 |
| WKN: | A3MQR6 |
| Listed: | Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt, Hamburg, Tradegate Exchange |
| EQS News ID: | 2152146 |
| End of News | EQS News Service |
|
|
2152146 06.06.2025 CET/CEST
Nachrichten zu Fonterelli SPAC 2 AG Inhaber-Akt
Analysen zu Fonterelli SPAC 2 AG Inhaber-Akt
10 Dividendenwunder für die Ewigkeit – Wall Street Live mit Tim Schäfer
Dividenden seit über 200 Jahren – Diese Aktien zahlen zuverlässig wie ein Uhrwerk!
Heute geht es um ein Thema, das besonders langfristig orientierte Anleger begeistert: Dividendenaktien mit jahrzehntelanger oder sogar jahrhundertelanger Historie. Gemeinsam mit Tim Schäfer @TimSchaeferMedia schauen wir uns Aktien an, die über 100 Jahre, teils sogar über 200 Jahre zuverlässig Dividenden zahlen – unabhängig von Krisen, Kriegen oder Pandemien.
Highlights der Folge:
🔹 York Water – Dividendenzahlung seit über 200 Jahren
🔹 ExxonMobil – Dividendenhistorie seit 1882, profitiert vom Ölpreis
🔹 Procter & Gamble – Cashmaschine mit Markenpower, zahlt seit 135 Jahren
🔹 Eli Lilly – Pharma-Gigant mit starker Entwicklung durch Abnehmspritze
🔹 Stanley Black & Decker – Value-Chance trotz aktueller Schwäche
🔹 Coca-Cola – Buffett-Favorit, Dividendenzahlung seit 1893
🔹 Johnson Controls – Spezialist für Gebäude- und Klimalösungen
🔹 PPG Industries – Farben und Beschichtungen seit 1899
🔹 Consolidated Edison – Versorger für New York mit konstanter Ausschüttung seit 1885
👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/
Inside Trading & Investment
Mini-Futures auf SMI
Inside Fonds
Aktien in diesem Artikel
| Fonterelli SPAC 2 AG Inhaber-Akt | 4.28 | -2.28% |
|
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
NVIDIA treibt den Techmarkt an: SMI mit Gewinnen -- DAX zeigt sich im Donnerstagshandel höher -- Asiens Börsen gehen uneinheitlich aus dem HandelAm heimischen Aktienmarkt geht es am Donnerstag nach oben. Der deutsche Aktienmarkt gewinnt daneben ebenfalls. An den Börsen in Asien entwickelten sich die Märkte uneinheitlich.
finanzen.net News
| Datum | Titel |
|---|---|
|
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
|
{{ARTIKEL.NEWS.BODY.TITEL}} |